Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation

Cardiovascular diseases (CVDs) are a major burden on the healthcare system: indeed, over two million new cases are diagnosed every year worldwide. Unfortunately, important drawbacks for the treatment of these patients derive from our current inability to stop the structural alterations that lead to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death Dis
Main Authors: Milan, Marika, Pace, Valentina, Maiullari, Fabio, Chirivì, Maila, Baci, Denisa, Maiullari, Silvia, Madaro, Luca, Maccari, Sonia, Stati, Tonino, Marano, Giuseppe, Frati, Giacomo, Puri, Pier Lorenzo, De Falco, Elena, Bearzi, Claudia, Rizzi, Roberto
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833837/
https://ncbi.nlm.nih.gov/pubmed/29371598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-017-0174-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados